Table 2.
Top seven EV-miRNAs differentially expressed in RNA-seq analysis (screening phase) organized by adjusted p.
| EV-miRNAs | log2 FC | padj | |
|---|---|---|---|
| CT versus CA | hsa-miR-320a | −2.03 | 6.94 × 10–5 |
| hsa-miR-126-5p | 2.7 | 1.23 × 10−4 | |
| hsa-miR-423-5p | –1.73 | 1.28 × 10−3 | |
| hsa-miR-378a-3p | −2.29 | 1.64 × 10−3 | |
| hsa-miR-185-5p | –1.81 | 1.64 × 10−3 | |
| hsa-miR-150-5p | 2.47 | 1.64 × 10−3 | |
| hsa-miR-4454 | 2.93 | 2.14 × 10−3 | |
| CT versus LA | hsa-miR-320a | −2.23 | 1.33 × 10−6 |
| hsa-miR-423-5p | −1.91 | 2.06 × 10−4 | |
| hsa-miR-744-5p | −1.75 | 4.67 × 10−3 | |
| hsa-miR-103a-3p | −1.52 | 5.55 × 10−3 | |
| hsa-miR-183-5p | 1.4 | 6.55 × 10−3 | |
| hsa-miR-126-5p | 2.31 | 6.55 × 10−3 | |
| hsa-let-7f-5p | 1.23 | 1.20 × 10−2 | |
| CT versus TNBC | hsa-miR-185-5p | −2.2 | 5.26 × 10−6 |
| hsa-miR-195-5p | −2.74 | 5.94 × 10−5 | |
| hsa-miR-150-5p | 3.4 | 5.94 × 10−5 | |
| hsa-miR-126-5p | 3.35 | 6.82 × 10−5 | |
| hsa-miR-320a | −1.79 | 6.98 × 10−5 | |
| hsa-miR-26a-5p | 2.18 | 6.98 × 10−5 | |
| hsa-miR-4454 | 3.61 | 2.07 × 10−3 | |
| LA versus TNBC | hsa-miR-4433b-5p | 2.233 | 2.52 × 10−5 |
| hsa-miR-26a-5p | 1.768 | 8.62 × 10−3 | |
| hsa-miR-142-5p | 1.853 | 1.83 × 10−2 | |
| hsa-let-7f-5p | −1.114 | 3.77 × 10−2 | |
| hsa-miR-484 | 1.275 | 3.77 × 10−2 | |
| hsa-miR-486-5p | 1.252 | 4.17 × 10−2 | |
| hsa-miR-15b-5p | 2.39 | 4.77 × 10−2 |
The table shows differentially expressed miRNAs between groups. The EV-miRNAs selected for RT-qPCR analysis are underlined and highlighted in bold. CT (Control), LA (Luminal A), TNBC (Triple-Negative), CA (Cancer: LA + TNBC), FC (fold change), padj (adjusted p).